10 September 2018
A new report by visiongain predicts that the Pre-Filled Syringes market will reach $6,940m in 2020. This forecast and others appear in Pre-Filled Syringes Market Forecast 2016-2026: Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injector & Autoinjectors, and Glass Pre-Filled Syringes published in April 2016. Visiongain is a business information provider based in London, UK.
The Pre-Filled Syringes Market Forecast 2016-2026 report examines the current and future trends in the growing pre-filled syringes market. Glass syringes have long dominated the market, however the improved characteristics of plastic syringes, an increasing adoption of autoinjectors and pen injectors, as well as the advent of needle-free delivery systems are posing a threat to the continued dominance of glass syringes. The large number of injectable drugs in the pipeline and increasing number of approved biosimilars is helping to spur demand for pre-filled syringes, despite newer oral therapies being much preferred by patients.
In this report, we examine in detail some of the main national markets in the market, analyse and forecast the major treatment areas that use pre-filled syringes, as well as forecast specific products that are delivered in pre-filled syringes. In addition, the report includes an in-depth discussion of the main companies in the market, including historical revenues and product details when available. Qualitative analysis of the market is given, taking into account governmental policy and regulation, safety, features and more.
Visiongain’s report provides revenue forecasts to 2026 for the Pre-Filled Syringes market, its leading national markets, therapeutics areas and products. The report discusses selected leading companies in the market. These companies include Becton, Dickinson and Company, Gerresheimer, Schott, Baxter, Nipro, Weigao, Unilife, Roselabs, SHL Group, Ypsomed, Haselmeier, Owen Mumford, Bespak and Datwyler.
Pre-Filled Syringes Market Forecast 2016-2026: Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injector & Autoinjectors, and Glass Pre-Filled Syringes adds to visiongain’s range of analytical reports on industries and markets in healthcare.
For an executive summary please contact:
Email: Sara Peerun on email@example.com
Tel: +44 (0) 20 7336 6100
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high quality, original analyses to inform their strategic decisions.
Global liposomal drug delivery devices market is projected to grow at a CAGR of 10.69% by 2032.
21 June 2022
The global nanotechnology in drug delivery market was valued at US$53.0 billion in 2021 and is projected to grow at a CAGR of 18.7% during the forecast period 2022-2032.
20 June 2022
The global respiratory drug delivery technologies market was valued at US$59.51 billion in 2022 and is projected to grow at a CAGR of 7.31% during the forecast period 2022-2032.
15 June 2022
The global artificial intelligence (AI) in drug discovery market was valued at US$791 million in 2021 and is projected to grow at a CAGR of 30.7% during the forecast period 2022-2032.